Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORCA risperidone discontinuation trial in children and adolescents
2014-003651-54Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in behavioral disorder comparing Continuation risperidone with Discontinuation to placebo (2 arms). Primary endpoint: Nisonger Child Behavior Rating Form-Typical IQ total disruptive behavior score. Started Oct 2015; status: active.
02
Drugs
risperidone
03
Conditions
behavioral disorder
Beyond the preview
Go deeper on 2014-003651-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003651-54.